In consultation: Guidance and quality standards
Showing 1 to 1 of 1
| Title | Consultation | Type | Consultation end date |
|---|---|---|---|
| Atezolizumab with chemotherapy for adjuvant treatment of stage 3 colorectal cancer with high microsatellite instability or mismatch repair deficiency [ID6646] | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators | Technology appraisal guidance |